Paul Wachter Net Worth & Insider Trades

Paul Wachter - Director, Avalanche Biotechnologies, Inc

As of June 17, 2015

What is Paul Wachter's Net Worth?

The current estimated net worth of Avalanche Biotechnologies, Inc's Director, Paul Wachter, is estimated to be about $1.43M . Paul Wachter owns about 39,161 units of Avalanche Biotechnologies, Inc common stock. In the last month at Avalanche Biotechnologies, Inc, Paul Wachter has sold an estimated value of $262.68K worth.

What is Paul Wachter's Past Insider Trading?

Paul Wachter's largest sale order was 1,192 units , worth over $47.52K on June 17, 2015. In total, Paul Wachter has made about 6 transactions over a month of their time at Avalanche Biotechnologies, Inc. Paul Wachter usually trades in May and June, with the busiest year in 2015.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Paul Wachter's Salary in 2020?

As Director of Avalanche Biotechnologies, Inc, Paul Wachter has a total base salary of $750,035 . Paul Wachter received compensation valued at about $23,059,878 in 2020 after becoming Director. The vast majority of their compensation came in the form of stock awards of $9,128,814 , option awards of $3,381,227 , other compensation of $8,899,802 .

What is Paul Wachter's' Mailing Address?

  • Mailing address is C/o Time Warner Inc. One Time Warner Center New York NY 10019 NY

Avalanche Biotechnologies, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Earnings Plans or Compensations
Other Compensation
Total
Alfred F. Kelly, Jr. 2020 $1,550,076 - $17,026,616 $4,562,500 - - $ $26,364,928
Alfred F. Kelly, Jr. 2019 $1,400,059 - $14,246,423 $4,312,489 - - $36,800 $24,265,771
Alfred F. Kelly, Jr. 2018 $1,300,038 - $8,693,984 $3,500,008 - - $26,416 $19,493,946
Vasant M. Prabhu 2020 $1,100,050 - $8,039,757 $2,124,987 $1,209 $1,209 $23,850 $13,049,853
Vasant M. Prabhu 2019 $1,000,040 - $6,493,501 $1,625,005 $1,372 $1,372 $26,800 $11,586,718
Vasant M. Prabhu 2018 $1,000,038 - $5,848,193 $1,999,994 $1,215 $1,215 $16,500 $12,569,940
Ryan McInerney 2020 $1,100,050 - $9,439,901 $2,624,994 $3,227 $3,227 $27,100 $14,955,272
Ryan McInerney 2019 $900,047 - $7,133,141 $1,825,008 $3,600 $3,600 $30,621 $12,088,417
Ryan McInerney 2018 $900,035 - $6,777,537 $2,250,003 $3,351 $3,351 $21,500 $13,286,026
Rajat Taneja 2020 $1,100,050 - $8,939,651 $2,500,007 $1,743 $1,743 $20,850 $14,322,301
Rajat Taneja 2019 $900,047 - $6,977,836 $1,712,503 $1,969 $1,969 $22,215 $11,810,570
Rajat Taneja 2018 $900,035 - $6,803,356 $2,125,007 $1,769 $1,769 $17,750 $13,154,517
Paul Fabara 2020 $750,035 - $9,128,814 $3,381,227 - - $8,899,802 $23,059,878
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1403161/000119312520309539/d75661ddef14a.htm

What are Avalanche Biotechnologies, Inc's Past Insider Trades?

Avalanche Biotechnologies, Inc's most recent insider trade came on June 17, 2015 by Mehdi Gasmi who sold 500 units worth $19.93K . In the last month, insiders at Avalanche Biotechnologies, Inc have sold an estimated value of $4.83M and bought an estimated value of $20.05K worth of shares. Insider trading is most common in June, with the busiest year in 2015. The most active traders at the company are Mark S Blumenkranz, Director,  Paul Wachter, Director,  and Mehdi Gasmi, SVPPharmaceutical Development .

Avalanche Biotechnologies, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1